162 related articles for article (PubMed ID: 35384340)
1. Association between preoperative serum Cystatin-C levels and postsurgical oncological prognosis in patients with PRCC: A retrospective cohort study.
Lu S; Li S
Cancer Med; 2022 Nov; 11(22):4112-4121. PubMed ID: 35384340
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
[TBL] [Abstract][Full Text] [Related]
3. Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma.
Guo S; Xue Y; He Q; He X; Guo K; Dong P; Yao K; Yang G; Chen D; Li Z; Li X; Qin Z; Liu Z; Cheng W; Guo C; Zhang M; Han H; Zhou F
PLoS One; 2017; 12(6):e0178823. PubMed ID: 28586363
[TBL] [Abstract][Full Text] [Related]
4. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
[TBL] [Abstract][Full Text] [Related]
5. High CENPA expression in papillary renal cell carcinoma tissues is associated with poor prognosis.
Li J; Li Q; Yuan Y; Xie Y; Zhang Y; Zhang R
BMC Urol; 2022 Sep; 22(1):157. PubMed ID: 36163007
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological features and prognostic analysis of papillary renal cell carcinoma].
Bo ES; Hong P; Zhang Y; Deng SH; Ge LY; Lu M; Li N; Ma LL; Zhang SD
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):615-620. PubMed ID: 35950382
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for the survival of patients with papillary renal cell carcinoma after surgical management.
Ren W; Gao X; Zhang X; Hu J; Li H; Zu X
Clin Transl Oncol; 2020 May; 22(5):725-733. PubMed ID: 31317521
[TBL] [Abstract][Full Text] [Related]
8. The preoperative serum cystatin-C as an independent prognostic factor for survival in upper tract urothelial carcinoma.
Tan P; Shi M; Chen J; Xu H; Xie N; Xu H; Jiang Y; Ai JZ; Liu LR; Yang L; Wei Q
Asian J Androl; 2019; 21(2):163-169. PubMed ID: 30416134
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Effect of Subclassification on Oncological Outcomes in Patients with Surgically Treated Localized Papillary Renal Cell Carcinoma: A Retrospective Propensity Score-matched Cohort Study.
Li S; Liu X; Chen X
J Cancer; 2022; 13(4):1193-1202. PubMed ID: 35281881
[No Abstract] [Full Text] [Related]
10. [Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study].
Waalkes S; Roos FC; Eggers H; Schumacher S; Janssen M; Wegener G; Thüroff JW; Hofmann R; Schrader M; Kuczyk MA; Schrader AJ;
Urologe A; 2011 Sep; 50(9):1125-9. PubMed ID: 21845424
[TBL] [Abstract][Full Text] [Related]
11. Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker.
Schmeusser BN; Biermann H; Nicaise EH; Ali AA; Patil DH; Midenberg E; Helman T; Armas-Phan M; Nabavizadeh R; Joshi SS; Narayan VM; Bilen MA; Psutka SP; Ogan K; Master VA
Oncologist; 2023 Dec; 28(12):e1219-e1229. PubMed ID: 37540787
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinoma.
Rosenkrantz AB; Sekhar A; Genega EM; Melamed J; Babb JS; Patel AD; Lo A; Najarian RM; Ahmed M; Pedrosa I
Eur Radiol; 2013 Feb; 23(2):579-87. PubMed ID: 22903703
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cystatin C in patients with nasopharyngeal carcinoma: a retrospective study of 1063 patients.
Yuan J; Xu M; Li J; Li N; Chen LZ; Feng QS; Zeng YX
Clinics (Sao Paulo); 2016 Jul; 71(6):338-43. PubMed ID: 27438568
[TBL] [Abstract][Full Text] [Related]
14. Identifying biomarkers of papillary renal cell carcinoma associated with pathological stage by weighted gene co-expression network analysis.
He Z; Sun M; Ke Y; Lin R; Xiao Y; Zhou S; Zhao H; Wang Y; Zhou F; Zhou Y
Oncotarget; 2017 Apr; 8(17):27904-27914. PubMed ID: 28427189
[TBL] [Abstract][Full Text] [Related]
15. Tumor contour irregularity on preoperative imaging: a practical and useful prognostic parameter for papillary renal cell carcinoma.
Dai C; Huang J; Li Y; Zhang S; Tan Q; Hou J; Tang Q; Hu X; Guo J; Zeng M; Wang H; Zhou J
Eur Radiol; 2021 Jun; 31(6):3745-3753. PubMed ID: 33211144
[TBL] [Abstract][Full Text] [Related]
16. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Nomogram to Predict Cancer-Specific Survival in Elderly Patients With Papillary Renal Cell Carcinoma.
Zhanghuang C; Wang J; Yao Z; Li L; Xie Y; Tang H; Zhang K; Wu C; Yang Z; Yan B
Front Public Health; 2022; 10():874427. PubMed ID: 35444972
[TBL] [Abstract][Full Text] [Related]
18. Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma.
Basile G; Rosiello G; Larcher A; Fallara G; Martini A; Re C; Cignoli D; Tian Z; Karakiewicz PI; Mottrie A; Bertini R; Necchi A; Raggi D; Salonia A; Briganti A; Montorsi F; Capitanio U
Urol Oncol; 2022 Aug; 40(8):384.e15-384.e21. PubMed ID: 35662498
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
Duan Y; Zhang D
J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
[TBL] [Abstract][Full Text] [Related]
20. The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort.
Klatte T; Gallagher KM; Afferi L; Volpe A; Kroeger N; Ribback S; McNeill A; Riddick ACP; Armitage JN; 'Aho TF; Eisen T; Fife K; Bex A; Pantuck AJ; Stewart GD
BMC Med; 2019 Oct; 17(1):182. PubMed ID: 31578141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
